Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · IEX Real-Time Price · USD
2.650
+0.150 (6.00%)
At close: Apr 18, 2024, 3:56 PM
2.550
-0.100 (-3.77%)
After-hours: Apr 18, 2024, 4:10 PM EDT

Armata Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1997
Revenue
4.535.514.470.82000.120.260.480.41
Upgrade
Revenue Growth (YoY)
-17.77%23.11%443.62%----55.77%-45.26%16.14%404.94%
Upgrade
Gross Profit
4.535.514.470.82000.120.260.480.41
Upgrade
Selling, General & Admin
11.657.448.287.979.272.527.598.416.716.85
Upgrade
Research & Development
33.7735.0220.0214.449.828.372.885.683.995.81
Upgrade
Other Operating Expenses
00000.666.775.89.5501.86
Upgrade
Operating Expenses
45.4242.4528.322.4119.7517.6616.2723.6410.714.52
Upgrade
Operating Income
-40.89-36.95-23.82-21.59-19.75-17.66-16.16-23.38-10.23-14.11
Upgrade
Interest Expense / Income
2.6300.060.630.931.010000
Upgrade
Other Expense / Income
25.53-0.03-0.73-0.03-1.2-1.97-2.02-3.98-9.64-37.22
Upgrade
Pretax Income
-69.05-36.92-23.16-22.18-19.48-16.7-14.14-19.39-0.5923.11
Upgrade
Income Tax
000000-1.3-0.56-0.070
Upgrade
Net Income
-69.05-36.92-23.16-22.18-19.48-16.7-12.84-18.84-0.5223.11
Upgrade
Preferred Dividends
00000005.4410.281.29
Upgrade
Net Income Common
-69.05-36.92-23.16-22.18-19.48-16.7-12.84-24.28-10.7921.82
Upgrade
Shares Outstanding (Basic)
36342416850000
Upgrade
Shares Outstanding (Diluted)
36342416850000
Upgrade
Shares Change
5.19%42.27%46.84%104.93%72.15%890.84%568.20%81.82%-8.08%190.85%
Upgrade
EPS (Basic)
-1.91-1.08-0.96-1.35-2.49-3.59-28.14-345.38-278.60589.40
Upgrade
EPS (Diluted)
-1.91-1.08-0.96-1.35-2.55-3.59-30.52-345.38-278.60-326.20
Upgrade
Free Cash Flow
-55.56-34.69-24.88-19.09-15.71-11.44-9.25-10.89-9.99-13.77
Upgrade
Free Cash Flow Per Share
-1.54-1.01-1.03-1.16-2.01-2.46-20.27-154.89-258.49-514.69
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%--100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-902.85%-670.77%-532.45%-2622.96%---14048.70%-8991.54%-2153.05%-3449.88%
Upgrade
Profit Margin
-1524.51%-670.24%-517.55%-2695.14%---11163.48%-9336.92%-2272.42%5335.94%
Upgrade
Free Cash Flow Margin
-1226.69%-629.85%-556.08%-2320.05%---8043.48%-4186.54%-2103.37%-3367.73%
Upgrade
EBITDA
-65.45-36.03-21.92-20.44-17.2-14.34-13.8-19.06-0.2923.24
Upgrade
EBITDA Margin
-1445.07%-654.05%-489.99%-2483.48%---11997.39%-7329.23%-61.05%5681.17%
Upgrade
Depreciation & Amortization
0.970.891.171.111.351.350.340.340.30.13
Upgrade
EBIT
-66.42-36.92-23.09-21.55-18.55-15.69-14.14-19.39-0.5923.11
Upgrade
EBIT Margin
-1466.53%-670.24%-516.12%-2618.83%---12295.65%-7459.23%-124.00%5650.12%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).